EMA updates on regulatory expectations amid Covid-19
The EMA on Monday updated its recent question and answer guideline on regulatory expectations for medicinal products amid the coronavirus disease (Covid-19) pandemic.
The guideline …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.